Pfizer Inc(PFE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 36.78 | EPS (ttm) | 0.76 | Insider Own | 0.09% | Shs Outstand | 5.70B | Perf Week | -2.7% |
| Market Cap | 158.34B | Forward P/E | 9.6 | EPS next Y | -2.67% | Insider Trans | 2.18% | Shs Float | 5.69B | Perf Month | 2.7% |
| Enterprise Value | 210.13B | PEG | - | EPS next Q | 0.76 | Inst Own | 69.8% | Short Float | 2.62% | Perf Quarter | 8.09% |
| Income | 4.33B | P/S | 2.49 | EPS this Y | -7.63% | Inst Trans | -0.4% | Short Ratio | 3.54 | Perf Half Y | 2.28% |
| Sales | 63.70B | P/B | 1.86 | EPS next 5Y | -8.27% | ROA | 2.13% | Short Interest | 149.27M | Perf YTD | 11.57% |
| Book/sh | 14.95 | P/C | 13.53 | EPS past 3/5Y | -37.19% -3.57% | ROE | 4.99% | 52W High | -4.9% ($29.21) | Perf Year | 12.42% |
| Cash/sh | 2.05 | P/FCF | 14.41 | Sales past 3/5Y | -14.56% 8.48% | ROIC | 2.97% | 52W Low | 17.81% ($23.58) | Perf 3Y | -18.89% |
| Dividend Est. | $1.72 (6.21%) | EV/EBITDA | 8.94 | EPS Y/Y TTM | -59.71% | Gross Margin | 64.83% | Volatility(W/M) | 1.78% 1.94% | Perf 5Y | -39.65% |
| Dividend TTM | 1.72 | EV/Sales | 3.3 | Sales Y/Y TTM | -0.21% | Oper. Margin | 26.57% | ATR (14) | 0.59 | Perf 10Y | -14.04% |
| Dividend Ex-Date | 2026/7/24 | Quick Ratio | 0.96 | EPS Q/Q | -108.6% | Profit Margin | 6.8% | RSI (14) | 53.75 | Recom | 2.54 |
| Dividend Gr. 3/5Y | 2.23% 2.37% | Current Ratio | 1.27 | Sales Q/Q | 2.6% | SMA20 | -0.39% ($27.89) | Beta | 0.28 | Target Price | $28.49 |
| Payout | 126.85% | Debt/Eq | 0.74 | Earnings | 2026/8/4 | SMA50 | 6.35% ($26.12) | Rel Volume | 0.68 | Prev Close | $27.79 |
| Employees | 75000 | LT Debt/Eq | 0.71 | EPS/Sales Surpr. | 12.87% 4.41% | SMA200 | 6.07% ($26.19) | Avg Volume(3M) | 42.16M | Price | $27.78 |
| IPO | 1944/1/17 | Option/Short | Yes/Yes | Trades | 89761 | Volume | 28,599,736 | Change | -0.04% |
Company
PFE is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 A global, diversified pharmaceutical company covering a wide range of therapeutic areas, including oncology, internal medicine, vaccines, and anti-infectives. Founded in 1849 and headquartered in the U.S., it has established itself as a key player among the global Big Pharma groups.
Over the past 1 year, roughly in the middle
5% below its 1-year high.
PFE earns at a steady pace
26.57% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -7.6% this year.
Tap to view numbers
The price looks about right
Trading at 36.8 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -18.9% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 6.21% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 69.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
OZEM 0.06%
FDL 0.06%
PJP 0.05%
SOLZ 0.05%
MJ 0.05%It ranks #4 in the industry
Based on market cap of $158B.
PFE $158B PER 36.8
LLY $1.1T PER 38.2
JNJ $644B PER 31.0
ABBV $443B PER 70.9
실적분석 · 8/4 Pfizer ($PFE) Q2 2026 Earnings Analysis — Adjusted EPS and Revenue Both Beat, Full-Year Revenue Outlook Raised, Shares Slightly Weaker After Hours 투자 가이드 · 4/11 2026 U.S. High-Dividend Stock Guide — How to Screen Out the Traps 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is PFE?
PFE belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is the market cap of PFE?
The market cap of PFE is approximately $158.3B, ranking 106 within its sector.
Does PFE pay dividends?
PFE has a dividend yield of approximately 6.21%, with an annual dividend of $1.72.
What is the P/E ratio of PFE?
PFE has a P/E ratio of approximately 36.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PFE?
PFE has recorded a 52-week high of $29.21 and a low of $23.58.
